4-(Cbz-amino)-1-benzylpiperidine

Catalog No. :
ACLRKT567
CAS No. :
182223-53-6
Molecular Formula :
C20H24N2O2
Molecular Weight :
324.42

IUPAC Name:benzyl (1-benzylpiperidin-4-yl)carbamate

4-(Cbz-amino)-1-benzylpiperidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$109.00Login to see priceInquiryInquiry
5g95%$358.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Cbz-amino)-1-benzylpiperidine
IUPAC Namebenzyl (1-benzylpiperidin-4-yl)carbamate
MDL No.MFCD16251209
Molecular FormulaC20H24N2O2
Molecular Weight324.42
SMILESO=C(OCC1=CC=CC=C1)NC2CCN(CC3=CC=CC=C3)CC2
InChI KeyVZHJWMOVSNSVSX-UHFFFAOYSA-N
Synonym1-Benzyl-4-benzyloxycarbonylaminopiperidine;4-(Cbz-aMino)-1-benzylpiperidine;[1-(Benzyl)-4-piperidinyl]carbaMic Acid Benzyl Ester;[1-(PhenylMethyl)-4-piperidinyl]carbaMic Acid PhenylMethyl Ester;Benzyl (1-Benzylpiperidin-4-yl)carbaMate;N-(Benzyloxycarbonyl)-1-benzylpiperidin-4- ylaMin;N-(Benzyloxycarbonyl)-1-benzylpiperidin-4-ylamine;Carbamic acid, [1-(phenylmethyl)-4-piperidinyl]-, phenylmethyl ester (9CI)
CAS No.182223-53-6
PubChem CID10687441

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACLRKT567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACISVW287 route compound structure diagram
    ACISVW28750541-93-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLRKT567 route product structure diagram
    ACLRKT567182223-53-6
Inquiry

2. ACLRKT567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACISVW287 route compound structure diagram
    ACISVW28750541-93-0 In Stock
  2. Then
  3. ACLRKT567 route product structure diagram
    ACLRKT567182223-53-6
Inquiry

Comments (0)